Skip to main content

Roche wins approval for cancer drug Kadcyla in fast-growing China market

* China is Roche's second-largest market behind the United States
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.